MedPath

The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.

Not Applicable
Conditions
living donor renal transplantation
Registration Number
JPRN-UMIN000014279
Lead Sponsor
Toho University School of Medicine, Department of Anesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients without written informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The concentrations of urinary liver-type fatty acid binding protein after renal transplantation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath